TickerFactsScreenerDevelopers

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$14.4K2010: -$620.8K2011: -$6.19M2012: -$2.24M2014: $8.63M2015: -$18.38M2016: -$32.67M2017: -$78.71M2018: -$101.25M2019: -$158.89M2020: -$205.13M2021: -$227.94M2022: -$292.76M2023: -$361.82M2024: -$352.98M2025: -$302.41M-$302.41M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$302.41M+14.3%
2024-$352.98M+2.4%
2023-$361.82M-23.6%
2022-$292.76M-28.4%
2021-$227.94M-11.1%
2020-$205.13M-29.1%
2019-$158.89M-56.9%
2018-$101.25M-28.6%
2017-$78.71M-140.9%
2016-$32.67M-77.7%
2015-$18.38M-312.9%
2014$8.63M—
2012-$2.24M+63.8%
2011-$6.19M-897.0%
2010-$620.8K-4196.8%
2009-$14.4K—